4//SEC Filing
MULE EDWARD A 4
Accession 0001193125-25-288480
CIK 0001567892other
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 6:39 PM ET
Size
10.9 KB
Accession
0001193125-25-288480
Insider Transaction Report
Form 4
MULE EDWARD A
10% Owner
Transactions
- Purchase
Common Stock
2025-11-19$88.88/sh+42,000$3,732,750→ 4,571,740 total - Purchase
Common Stock
2025-11-17$88.88/sh+26,000$2,310,750→ 4,529,740 total
Silver Point Capital L.P.
10% Owner
Transactions
- Purchase
Common Stock
2025-11-17$88.88/sh+26,000$2,310,750→ 4,529,740 total - Purchase
Common Stock
2025-11-19$88.88/sh+42,000$3,732,750→ 4,571,740 total
O'Shea Robert J
10% Owner
Transactions
- Purchase
Common Stock
2025-11-17$88.88/sh+26,000$2,310,750→ 4,529,740 total - Purchase
Common Stock
2025-11-19$88.88/sh+42,000$3,732,750→ 4,571,740 total
Footnotes (3)
- [F1]Includes 16 shares that were inadvertently omitted from the prior filings.
- [F2]Silver Point Capital, L.P. ("Silver Point") or its wholly owned subsidiaries are the investment managers of Silver Point Capital Fund, L.P., Silver Point Capital Offshore Master Fund, L.P., Silver Point Distressed Opportunity Institutional Partners, L.P., Silver Point Distressed Opportunity Institutional Partners Master Fund (Offshore), L.P., Silver Point Distressed Opportunities Fund, L.P., Silver Point Distressed Opportunities Offshore Master Fund, L.P., Silver Point Distressed Opportunity Institutional Partners II, L.P. and Silver Point Distressed Opportunity Institutional Partners II (Offshore), L.P. (the "Funds") and, by reason of such status, may be deemed to be the beneficial owner of all the reported securities held by the Funds.
- [F3](Continued from footnote 2) Silver Point Capital Management, LLC ("Management") is the general partner of Silver Point and as a result may be deemed to be the beneficial owner of all securities held by the Funds. Messrs. Edward A. Mule and Robert J. O'Shea are each members of Management and as a result may be deemed to be the beneficial owner of all of the securities held by the Funds. Messrs. Mule and O'Shea disclaim beneficial ownership of the reported securities held by Funds except to the extent of their pecuniary interests.
Documents
Issuer
Keenova Therapeutics plc
CIK 0001567892
Entity typeother
Related Parties
1- filerCIK 0001029625
Filing Metadata
- Form type
- 4
- Filed
- Nov 18, 7:00 PM ET
- Accepted
- Nov 19, 6:39 PM ET
- Size
- 10.9 KB